The trend of VEGF-A and PIGF in pregnant patients: A perspective case-control study on 214 women

Clinical and Experimental Obstetrics and Gynecology

Volumn 39, Issue 1, 2012, Pages 57-64

  Patrelli, T S ^a,b   Gizzo, S ^a   Plebani, M ^a   Basso, D ^c   Capobianco, G ^d   Bartolucci, C ^a   Bacchi Modena, A ^b   Rondinelli, M ^a   Nardelli, G B ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^d UNIVERSITY OF SASSARI   (Italy)

Author keywords

Abortion; Ectopic pregnancy; IUGR; PLGF; Preeclampsia; Pregnancy; Preterm delivery; Twin pregnancies; VEGF

Indexed keywords

PLACENTAL GROWTH FACTOR; VASCULOTROPIN A; BIOLOGICAL MARKER; PLACENTA PROTEIN; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ECTOPIC PREGNANCY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMALE FERTILITY; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; IMMINENT ABORTION; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MENOPAUSE; MULTIPLE PREGNANCY; PLACENTA PREVIA; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PROSPECTIVE STUDY; RANK SUM TEST; SECOND TRIMESTER PREGNANCY; SPONTANEOUS ABORTION; STATISTICAL SIGNIFICANCE; THIRD TRIMESTER PREGNANCY; UTERUS CONTRACTILITY; ADOLESCENT; BLOOD; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84860857525     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. LeCouter J., Kowalski J., Foster J., Hass P., Zhang Z., Dillard-Telm L. et al.: "Identification of an angiogenic mitogen selective for endocrine gland endothelium". Nature, 2001, 412, 877.
2. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J.: "Vascular-specific growth factors and blood vessel formation". Nature, 2000, 407, 242.
3. Tjwa M., Luttun A., Autiero M., Carmeliet P.: "VEGF and PIGF: two pleiotropic growth factors with distinct roles in development and homeostasis". Cell. Tissue Res., 2003, 314, 5.
4. Pugh C.W., Ratcliffe P.J.: "Regulation of angiogenesis by hypoxia: role of the HIF system". Nat. Med., 2003, 9, 677.
5. Brusselmans K., Bono F., Maxwell P., Dor Y., Dewerchin M., Collen D. et al.: "Hypoxia-inducible factor-2alpha (HIF-2alpha) is involved in the apoptotic response to hypoglycemia but not to hypoxia". J. Biol. Chem., 2001, 276, 39192.
6. Neufeld G., Cohen T., Gengrinovitch S., Poltorak Z.: "Vascular endothelial growth factor (VEGF) and its receptors". FASEB J., 1999, 13, 9.
7. Shibuya M., Yamaguchi S., Yamane A., Ikeda T., Tojo A., Matsushime H., Sato M.: "Nucleotide sequence and expression of novel human receptor type tyrosine kinase gene (flt) closely related to the fms family". Oncogene, 1990, 5, 519.
8. Tammela T., Enholm B., Alitalo K., Paavonen K.: "The biology of vascular endothelial growth factors". Cardiovasc. Res., 2005, 65, 550.
9. Nagy J.A., Dvorak A.M., Dvorak H.F.: "VEGF-A and PIGF: roles in angiogenesis and arteriogenesis". Trends Cardiovasc. Med., 2003, 13, 169.
10. Partanen T.A., Alitalo K., Miettinen M.: "Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors". Cancer, 1999, 86, 2406.
11. Fong G.H., Rossant J., Gertsenstein M., Breitman M.L.: "Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium". Nature, 1995, 376, 66.
12. Ferrera N., Gerber H.P., LeCouter J.: "The biology of VEGF and its receptors". Nat. Med., 2003, 9, 669.
13. Gille H., Kowalski J., Li B., LeCouter J., Moffat B., Zioncheck T.F. et al.: "Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants". J. Biol. Chem., 2001, 276, 3222.
14. Meyer M., Clauss M., Lepple-Wienhues A., Waltenberger J., Augustin H.G., Ziehe M. et al.: "A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases". EMBO J., 1999, 18, 363.
15. Autiero M., Waltenberger J., Communi D., Kranz A., Moons L., Lambrechts D. et al.: "Role of PlGF in the intra and intermolecular cross talk between the VEGF receptors Flt-1 and Flk-1". Nat. Med., 2003, 9, 936.
16. Luttun A., Tjwa M., Moons L., Wu Y., Angelillo-Scherrer A., Liao F. et al.: "Revascularization of ischemic tissues by PIGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt-1". Nat. Med., 2002, 8, 831.
17. Achen M.G., Gad J.M., Stacker S.A., Wilks A.F.: "Placenta growth factor and vascular endothelial growth factor are co-expressed during early embryonic development". Growth factors, 1997, 15, 69.
18. Wheeler T., Elcock T.L., Antony F.W.: "Angiogenesis and placental environment". Placenta, 1995, 16, 289.
19. Lang I., Pabst M.A., Hiden U., Blaschitz A., Dohr G., Hahn T.: "Heterogeneity of microvascular endothelial cells isolated from human term placenta and macrovascular umbilical vein endothelial cells". Eur. J. Cell. Biol., 2003, 82, 163.
20. Ziehe M., Maglione D., Ribatti D., Morbidelli L., Lago C.T., Battisti M.: "Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic". Lab. Invest., 1997, 76, 517.
21. Shore V.H., Wang T.-H., Wang C.-L., Torry R.J., Caudle M.R., Torry D.S.: "Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast". Placenta, 1997, 18, 657.
22. Kaufmann P., Luckhardt M., Leiser R.: "Three-dimensional representation of the fetal vessel system in the human placenta". Trophoblast Res., 1988, 3, 113.
23. Kaufmann P., Mayhew T.M., Charnock-Jones D.S.: "Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy". Placenta, 2004, 25, 114.
24. Tranquilli A.L., Giannubilo S.R., Bezzeccheri V., Ciavattini A., Scagnoli C., Mazzanti L.: "Amniotic levels of nitric oxide and vascular endothelial growth factor in pregnancy with subsequent intrauterine fetal death". Eur. J. Obstet. Gynecol. Reprod. Biol., 2004, 114, 162.
25. Morris N.H., Eaton B.M., Dekker G.: "Nitric oxide, the endothelium, pregnancy and preeclampsia". Br. J. Obstet. Gynaecol., 1996, 103, 4.
26. Di Iorio R., Marinoni E., Coacci F., La Torre R., Cosmi E.V.: "Amniotic fluid nitric oxide and uteroplacental blood flow in pregnancy complicated by intrauterine growth retardation". Br. J. Obstet. Gynaecol., 1997, 104, 1134.
27. Letterie G.S., Hibbert M.: "Serial serum human chorionic gonadotropin (HCG) levels in ectopic pregnancy and first trimester miscarriage". Arch. Gynecol. Obstet., 2000, 263, 168.
28. Minchenco A., Salceda S., Bauer T., Caro J.: "Hypoxia regulatory elements of the human vascular endothelial growth factor gene". Cell Mol. Biol. Res., 1994, 40, 35.
29. Mueller M.D., Vigne J.L., Michenco A., Lebovic D.I., Leitman D.C., Taylor R.N.: "Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta". Proc. Natl. Acad. Sci USA, 2000, 97, 10972.
30. Lebovic D.I., Mueller M.D., Taylor R.N.: "Vascular endothelial growth factor in reproductive biology". Curr. Opin. Obstet. Gynecol., 1999, 11, 255.
31. Papazoglu D., Galazios G., Papatheodor K., Liberis V., Papanas N., Maltezos E., Maroulis G.B.:"Vascular endothelial growth factor gene polymorphisms and idiopathic recurrent pregnancy loss". Fertil. Steril., 2005, 83, 959.
32. Mueller M.D., Raio L., Spoerri S., Ghezzi F., Dreher E., Bersinger N.A.: "Novel placental and non-placental serum markers in ectopic versus normal intrauterine pregnancy". Fertil. Steril., 2004, 81, 1106.
33. Regnault T.R., Orbus R.J., de Vrijer B., Davidsen M.L., Galan H.L., Wilkening R.B., Anthony R.V.: "Placental expression of VEGF, PIGF and their receptors in a model of insufficiency intrauterine growth restriction (PI-IUGR)". Placenta, 2002, 23, 132.
34. Ahmed A., Perkins J.: "Angiogenesis and intrauterine growth restriction". Baillieres Best Pract. Res. Clin. Obstet. Gynaecol., 2000, 14, 981.
35. Resnik R.: "Intrauterine growth restriction". Obstet. Gynecol., 2002, 99, 490.
36. Marsál K.: "Intrauterine growth restriction". Curr. Opin. Obstet. Gynecol., 2002, 14, 127.
37. Grutzkau A., Kruger-Krasagakes S., Baumeister H., Schwartz C., Kogel H., Welker P. et al.: "Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206". Mol. Biol. Cell, 1998, 9, 875.
38. Maynard S.E., Min J.-Y., Merchan J., Lim K.-H., Li J., Mondal S., Libermann T.A. et al.: "Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia". J. Clin. Invest., 2003, 111, 649.
39. Chaiworapongsa T., Romero R., Espinoza J., Bujold E., Mee Kim Y., Gonçalves L.F. et al.: "Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award". Am J Obstet Gynecol., 2004, 190, 1541.
40. Levine R.J., Maynard S.E., Qian C., Lim K.-H., England L.J., Yu K.F. et al.: "Circulating angiogenic factors and the risk of preeclampsia". N. Engl. J. Med., 2004, 350, 672.
41. Polliotti B.M., Fry A.G., Saller D.N., Mooney R.A., Cox C., Miller R.K.: "Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe early-onset preeclampsia". Obstet. Gynecol., 2003, 101, 1266.
42. Bosio P.M., Wheeler T., Anthony F., Conroy R., O'Herlihy C., McKenna P.: "Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance". Am. J. Obstet. Gynecol., 2001, 184, 146.